Last week in GLP1 (2025/09/01)
Here’s what happened last week in the GLP1 ecosystem:
📑 Orforglipron Phase 3 trial results landed
📢 TEVA Pharmaceuticals announced FDA approval for weight loss with Liraglutide
🎤 Meghan Trainor has been in the news after a GLP1 transformation
🎾 Serena Williams has shared her GLP1 story
Go deeper, read more
Here are our 3 latest deep dives on the recent news and research behind GLP1s:
💊 More research readouts on Orforglipron
The trials are going well, and Orforglipron continues to be effective.
GLP1 Guide
🇨🇦 GLP1s approved by Canada for Kidney and Heart Health
Official acceptance of GLP1s as a kidney and heart health positive solution
GLP1 Guide
📰 Cheaper Wegovy and an FDA approval for Novo Nordisk
A great week for the Danish Pharamaceutical
GLP1 Guide